Table 2.

Oligonucleotide primers

Oligonucleotide primers	Sequence (designed restriction sites are underlined)
PhaP1 NdeI	5′-GGAATTCCATATGATGTTCAAGGTTGAAGACTT-3′
PhaP1 XhoI	5′-CCGCTCGAGTTAGTTGGCGGCCGGGGTGA-3′
PhaP2 NdeI	5′-GGAATTCCATATGGTGAGTGATGCCGATATGAA-3′
PhaP2 XhoI	5′-CCGCTCGAGTCAAGCAGCCCTATGCAGAA-3′
PhaP3 NdeI	5′-GGAATTCCATATGATGATCGAACCGAAAATCGA-3′
PhaP3 XhoI	5′-CCGCTCGAGTCAGGATTTGCCCTTGCCCG-3′
PhaP4 NdeI	5′-GGAATTCCATATGATGACAGGTGCGACTGATCC-3′
PhaP4 HindIII	5′-CCCAAGCTTTCAGGCGGCGGGCGGGTAGA-3′
PhaR NdeI	5′-GGAATTCCATATGGCGAAATCAGACCAACCCAC-3′
PhaR HindIII	5′-CCCAAGCTTCTACTCTTCCTTCTTCGACA-3′
RTphbA1-F	5′-CATCGCCGTCAACAAGGA-3′
RTphbA1-R	5′-CCGCTTCTGCATCTCGAAC-3′
RTphbA2-F	5′-AAGAAGGCCGGCTGGAA-3′
RTphbA2-R	5′-CCATTGACGTTGACCTTGGA-3′
RTphbB1-F	5′-TCGAACTACGACGCCTGTG-3′
RTphbB1-R	5′-ATGCCGTCCTTGGTGATG-3′
RTphbB2-F	5′-CCGAAGGCGTGAAGAAGGT-3′
RTphbB2-R	5′-GAACAGCGAGCCGAGATTG-3′
RTphbC1-F	5′-GCTCTGGGAAAACATCTGGAAC-3′
RTphbC1-R	5′-TTGGTGATGGTGCGGAAA-3′
RTphbC2-F	5′-GGACGACTACGTTGAGGATGG-3′
RTphbC2-R	5′-AATGGCGAGTGCGGATG-3′
RTphbC3-F	5′-ATGACCGCGTCGAACCA-3′
RTphbC3-R	5′-GGCACCTTGACCTTGGAGA-3′
RTphbC4-F	5′-GGCGAAGACAGGCAAACA-3′
RTphbC4-R	5′-CTCCATCCATCCGAACCA-3′
RTphbC5-F	5′-CCGCAAAATTCCCTGGTC-3′
RTphbC5-R	5′-CATCCCTGTCCTTCGCATC-3′
RTphaZ1-F	5′-CCGAAGCAACGCACACA-3′
RTphaZ1-R	5′-ATCCTCGGCACGATTTCC-3′
RTphaZ2-F	5′-GGCACATCAAGCAGCACA-3′
RTphaZ2-R	5′-AGATCCATCACCGCGAAA-3′
RTphaP1-F	5′-ACGGCGACTACACCAAGAAG-3′
RTphaP1-R	5′-GAAGGTCTCGTAGGCGGAAC-3′
RTphaP2-F	5′-TCGCTTTTACCGAGCAGAAC-3′
RTphaP2-R	5′-GTGAACTGGCTACGCAGGA-3′
RTphaP3-F	5′-ATTACGGCACCAAGGTCATC-3′
RTphaP3-R	5′-GTGGAGAGGTTCACGAGGTC-3′
RTphaP4-F	5′-GTGCGACTGATCCATTCTCC-3′
RTphaP4-R	5′-GTCCTTGAACTTGGCGTAGC-3′
RTphaR-F	5′-CTTCGAGCAGGAGAACAAGG-3′
RTphaR-R	5′-GATATTTCGGCACCACCATC-3′
RTsigA-F	5′-CAGGCGAAGGACAAGGAAAA-3′
RTsigA-R	5′-CGTCGGACAGATCGAGCAA-3′